|
Aloisine A |
|
|
ALX-270-385-M001 |
|
1 mg |
30.00 USD |
|
 |
|
|
Anisomycin |
|
|
ALX-380-051-M010 |
|
10 mg |
35.00 USD |
|
|
|
ALX-380-051-M050 |
|
50 mg |
140.00 USD |
|
|
|
ALX-380-051-M100 |
|
100 mg |
250.00 USD |
|
|
|
|
AS601245 |
|
|
ALX-270-443-M001 |
|
1 mg |
50.00 USD |
|
|
|
ALX-270-443-M005 |
|
5 mg |
150.00 USD |
|
|
|
ALX-270-443-M025 |
|
25 mg |
520.00 USD |
|
|
|
|
(-)-Epigallocatechin gallate |
|
|
ALX-270-263-M010 |
|
10 mg |
20.00 USD |
|
|
|
ALX-270-263-M050 |
|
50 mg |
60.00 USD |
|
|
|
|
JNK Inhibitor 1 (L-stereoisomer) |
|
|
ALX-159-600-R100 |
|
100 µl |
125.00 USD |
|
|
|
ALX-159-600-R200 |
|
200 µl |
225.00 USD |
|
|
|
|
LL-Z1640-2 |
|
|
ALX-380-267-M001 |
|
1 mg |
50.00 USD |
|
|
|
ALX-380-267-M005 |
|
5 mg |
200.00 USD |
|
|
|
|
Control Peptide for Prod. No. ALX-159-600 |
|
|
ALX-168-009F-R050 |
FITC |
50 µl |
110.00 USD |
|
|
|
|
MAb to JNK/p38 (phosphorylated) (9H8) |
|
|
ALX-804-241-C100 |
|
100 µg |
453.00 USD |
|
|
|
|
N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxyphenyl)acetamide |
|
|
ALX-270-489-M005 |
|
5 mg |
210.00 USD |
|
|
|
|
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-1-naphthylamide |
|
|
ALX-270-490-M005 |
|
5 mg |
180.00 USD |
|
|
|
|
SP600125 |
|
|
ALX-270-339-M005 |
|
5 mg |
52.00 USD |
|
|
|
ALX-270-339-M025 |
|
25 mg |
190.00 USD |
|
|
|
 |
|
|
Control Peptide for Prod. No. ALX-159-601 |
|
|
ALX-168-010-R025 |
|
25 µl |
95.00 USD |
|
|
|
ALX-168-010F-R025 |
FITC |
25 µl |
145.00 USD |
|
|
|
|
Control Peptide for Prod. No. ALX-159-600 |
|
|
ALX-168-009/1-R050 |
|
50 µl |
40.00 USD |
|
|
|
|
Troy (human):Fc (human) (recombinant) |
|
|
ALX-522-045-C050 |
|
50 µg |
360.00 USD |
|
|
|
